Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
A growing amount of evidence indicates that matrix metalloproteinases (MMPs) may play an important role in the pathogenesis of Alzheimer's disease (AD). Stromelysin-1 (MMP-3) plays a central role in activating latent-type MMPs, which are originally secreted as proenzymes. We examined MMP-3 immunoreactivity in the brains of patients who had suffered from Alzheimer's disease and in those of neurologically normal persons. The interstitium between myelinated axons and astrocytes in the white matter of all brain tissues, and senile plaques in the gray matter of the patients with AD were stained with a monoclonal antibody to MMP-3. Comparison of the number of senile plaques stained with the antibody against MMP-3 in the parietal cortex with that in the hippocampus showed that fewer plaques were stained in the hippocampus. The selective distribution of MMP-3 in the human brain suggests that MMP-3 might play an important role in the pathogenesis of AD, especially in the degradation of beta-amyloid protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Enhanced expression of MMP-2 and MMP-9 has been found in astrocytes surrounding amyloid plaques and in the neurons and glia of the hippocampus after intracerebroventricular Ab injection (25)(26)(27)(28).”
From Differential protective effects of connective tissue growth factor against Aβ neurotoxicity on neurons and glia (2017) · cites this paper as [27]
In the citing paper
“while increased levels of metaloproteinases MMP-1, MMP-3 and MMP-10 have also been reported in AD [223,224,225,226].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [226]
Citations
Cites
Alzheimer's Disease: A Central Role for Amyloid
Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 751
Multiple domains of the large fibroblast proteoglycan, versican.
Zimmermann, D. R., & Ruoslahti, E. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08447.x · Cited by 652
A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor
Miyazaki, K., Hasegawa, M., Funahashi, K., & Umeda, M. (1993) · Nature · doi:10.1038/362839a0 · Cited by 175
Su, J. H., Cummings, B. J., & Cotman, C. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90521-3 · Cited by 173
Deb, S., & Gottschall, P. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041641.x · Cited by 163
Snow, A. D., Mar, H., Nochlin, D., Kresse, H., & Wight, T. N. (1992) · Journal of Histochemistry & Cytochemistry · doi:10.1177/40.1.1370306 · Cited by 144
Backstrom, J. R., Miller, C. A., & Tökés, Z. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09352.x · Cited by 109
Roughley, P. J., White, R. J., & Poole, A. R. (1985) · Biochemical Journal · doi:10.1042/bj2310129 · Cited by 93
Yamada, T., Yoshiyama, Y., Sato, H., Seiki, M., Shinagawa, A., & Takahashi, M. (1995) · Acta Neuropathologica · doi:10.1007/bf00294800 · Cited by 85
Self-citationIsolation of a large aggregating proteoglycan from human brain.
Perides, G., Rahemtulla, F., Lane, W. S., Asher, R. A., & Bignami, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35919-2 · Cited by 73
Cited by
Physiology and pathophysiology of matrix metalloproteases
Klein, T., & Bischoff, R. (2011) · Amino Acids · doi:10.1007/s00726-010-0689-x · Cited by 828
“2003), Alzheimer’s disease (Yoshiyama et al. 2000) and various cancers (Mercapide et al.”
BackgroundMatrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
Rempe, R. G., Hartz, A. M., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 721
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
Rosenberg, G. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70016-x · Cited by 594
Galtrey, C. M., & Fawcett, J. W. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.09.006 · Cited by 575
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Metadata
- Authors
- Yoshiyama, Y., Asahina, M., & Hattori, T.
- Affiliations
- Chiba University (JP)
- Venue
- Acta Neuropathologica
- Published
- 2000-01-05
- Volume
- 99
- Issue
- 2
- Pages
- 91-95
- ISSN
- 0001-6322 (ISSN-L)
- OpenAlex
- W2033779398
- Cited by
- 128
- References
- 11
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 1 · 2023: 8 · 2022: 3 · 2021: 10 · 2020: 8 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 8 · 2013: 8 · 2012: 5
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- matrix metalloproteinase-3, stromelysin-1, Alzheimer's disease, amyloid plaques, white matter, hippocampus, parietal cortex, MMP activation
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Antibodies, Monoclonal, Astrocytes, Axons, Brain, Female, Hippocampus, Humans, Immunohistochemistry, Male, Middle Aged, Parietal Lobe, Reference Values, Matrix Metalloproteinase 3, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.